{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T12:46:27Z","timestamp":1763729187156,"version":"3.45.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"University Grants Commission, India","award":["16-8(June 2018)\/2019(NET\/CSIR)"],"award-info":[{"award-number":["16-8(June 2018)\/2019(NET\/CSIR)"]}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["DST\/CSRI\/2018\/70 (G)"],"award-info":[{"award-number":["DST\/CSRI\/2018\/70 (G)"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11030-024-11101-6","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T01:39:30Z","timestamp":1738028370000},"page":"5855-5876","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Inhibition of amyloid-beta aggregation by phenyl butyric acid analogs and bile acids: a comprehensive in silico study"],"prefix":"10.1007","volume":"29","author":[{"given":"Rimaljot","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiwani","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neelima","family":"Dhingra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanzeer","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,28]]},"reference":[{"key":"11101_CR1","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.14506.1","author":"J Weller","year":"2018","unstructured":"Weller J, Budson A (2018) Current understanding of Alzheimer\u2019s disease diagnosis and treatment. F1000Research. https:\/\/doi.org\/10.12688\/f1000research.14506.1","journal-title":"F1000Research"},{"key":"11101_CR2","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.jocn.2003.12.007","volume":"11","author":"MS Parihar","year":"2004","unstructured":"Parihar MS, Hemnani T (2004) Alzheimer\u2019s disease pathogenesis and therapeutic interventions. J Clin Neurosci 11:456\u2013467. https:\/\/doi.org\/10.1016\/j.jocn.2003.12.007","journal-title":"J Clin Neurosci"},{"key":"11101_CR3","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","volume":"388","author":"P Scheltens","year":"2016","unstructured":"Scheltens P, Blennow K, Breteler MMB et al (2016) Alzheimer\u2019s disease. Lancet (London, England) 388:505\u2013517. https:\/\/doi.org\/10.1016\/S0140-6736(15)01124-1","journal-title":"Lancet (London, England)"},{"key":"11101_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.17265\/2328-7136\/2017.01.002","volume":"5","author":"S Mimori","year":"2017","unstructured":"Mimori S, Hosoi T, Kaneko M et al (2017) Neuroprotective effects of 4-phenylbutyric acid and its derivatives: possible therapeutics for neurodegenerative diseases. J Heal Sci 5:9\u201317. https:\/\/doi.org\/10.17265\/2328-7136\/2017.01.002","journal-title":"J Heal Sci"},{"key":"11101_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s12640-018-9932-0","volume":"35","author":"A Bhardwaj","year":"2019","unstructured":"Bhardwaj A, Bhardwaj R, Dhawan DK, Kaur T (2019) Exploring the effect of endoplasmic reticulum stress inhibition by 4-phenylbutyric acid on AMPA-induced hippocampal excitotoxicity in rat brain. Neurotox Res 35:83\u201391. https:\/\/doi.org\/10.1007\/s12640-018-9932-0","journal-title":"Neurotox Res"},{"key":"11101_CR6","doi-asserted-by":"publisher","DOI":"10.1080\/1028415X.2020.1859729","author":"E Cuevas","year":"2020","unstructured":"Cuevas E, Burks S, Raymick J et al (2020) Tauroursodeoxycholic acid (TUDCA) is neuroprotective in a chronic mouse model of Parkinson\u2019s disease. Nutr Neurosci. https:\/\/doi.org\/10.1080\/1028415X.2020.1859729","journal-title":"Nutr Neurosci"},{"key":"11101_CR7","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1007\/s00018-009-8746-x","volume":"66","author":"RJS Viana","year":"2009","unstructured":"Viana RJS, Nunes AF, Castro RE et al (2009) Tauroursodeoxycholic acid prevents E22Q Alzheimer\u2019s Abeta toxicity in human cerebral endothelial cells. Cell Mol Life Sci 66:1094\u20131104. https:\/\/doi.org\/10.1007\/s00018-009-8746-x","journal-title":"Cell Mol Life Sci"},{"key":"11101_CR8","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s12035-012-8256-y","volume":"45","author":"AF Nunes","year":"2012","unstructured":"Nunes AF, Amaral JD, Lo AC et al (2012) TUDCA, a bile acid, attenuates amyloid precursor protein processing and amyloid-\u03b2 deposition in APP\/PS1 mice. Mol Neurobiol 45:440\u2013454. https:\/\/doi.org\/10.1007\/s12035-012-8256-y","journal-title":"Mol Neurobiol"},{"key":"11101_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s12010-023-04625-4","author":"N Kaur","year":"2023","unstructured":"Kaur N, Singh R, Das AP et al (2023) Identification of bile acid-derived chemical chaperone(s) targeting E46K-mutated alpha-synuclein protein to treat Parkinson\u2019s disease: molecular modelling, docking, ADME, and simulation studies. Appl Biochem Biotechnol. https:\/\/doi.org\/10.1007\/s12010-023-04625-4","journal-title":"Appl Biochem Biotechnol"},{"key":"11101_CR10","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/nsb0902-646","volume":"9","author":"M Karplus","year":"2002","unstructured":"Karplus M, McCammon JA (2002) Molecular dynamics simulations of biomolecules. Nat Struct Biol 9:646\u2013652. https:\/\/doi.org\/10.1038\/nsb0902-646","journal-title":"Nat Struct Biol"},{"key":"11101_CR11","doi-asserted-by":"publisher","DOI":"10.13172\/2054-4057-1-1-1119","author":"A Wadood","year":"2013","unstructured":"Wadood A, Ahmed N, Shah L et al (2013) In-silico drug design: an approach which revolutionarised the drug discovery process. OA Drug Des Deliv. https:\/\/doi.org\/10.13172\/2054-4057-1-1-1119","journal-title":"OA Drug Des Deliv"},{"key":"11101_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.cbi.2006.12.006","volume":"171","author":"IM Kapetanovic","year":"2008","unstructured":"Kapetanovic IM (2008) Computer-aided drug discovery and development (CADDD): in silico-chemico-biological approach. Chem Biol Interact 171:165\u2013176. https:\/\/doi.org\/10.1016\/j.cbi.2006.12.006","journal-title":"Chem Biol Interact"},{"key":"11101_CR13","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1248\/bpb.35.84","volume":"35","author":"S Mimori","year":"2012","unstructured":"Mimori S, Okuma Y, Kaneko M et al (2012) Protective effects of 4-phenylbutyrate derivatives on the neuronal cell death and endoplasmic reticulum stress. Biol Pharm Bull 35:84\u201390. https:\/\/doi.org\/10.1248\/bpb.35.84","journal-title":"Biol Pharm Bull"},{"key":"11101_CR14","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1246\/cl.130419","volume":"42","author":"S Mimori","year":"2013","unstructured":"Mimori S, Okuma Y, Kaneko M et al (2013) Discovery of synthetic methoxy-substituted 4-phenylbutyric acid derivatives as chemical chaperones. Chem Lett 42:1051\u20131052. https:\/\/doi.org\/10.1246\/cl.130419","journal-title":"Chem Lett"},{"key":"11101_CR15","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.bmcl.2014.12.080","volume":"25","author":"S Mimori","year":"2015","unstructured":"Mimori S, Koshikawa Y, Mashima Y et al (2015) Evaluation of synthetic naphthalene derivatives as novel chemical chaperones that mimic 4-phenylbutyric acid. Bioorganic Med Chem Lett 25:811\u2013814. https:\/\/doi.org\/10.1016\/j.bmcl.2014.12.080","journal-title":"Bioorganic Med Chem Lett"},{"key":"11101_CR16","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nsmb.2991","volume":"22","author":"Y Xiao","year":"2015","unstructured":"Xiao Y, Ma B, McElheny D et al (2015) A\u03b2(1\u201342) fibril structure illuminates self-recognition and replication of amyloid in Alzheimer\u2019s disease. Nat Struct Mol Biol 22:499\u2013505. https:\/\/doi.org\/10.1038\/nsmb.2991","journal-title":"Nat Struct Mol Biol"},{"key":"11101_CR17","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner RA, Murphy RB, Repasky MP et al (2006) Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem 49:6177\u20136196. https:\/\/doi.org\/10.1021\/jm051256o","journal-title":"J Med Chem"},{"key":"11101_CR18","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner RA, Banks JL, Murphy RB et al (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47:1739\u20131749. https:\/\/doi.org\/10.1021\/jm0306430","journal-title":"J Med Chem"},{"key":"11101_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/s0169-409x(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46:3\u201326. https:\/\/doi.org\/10.1016\/s0169-409x(00)00129-0","journal-title":"Adv Drug Deliv Rev"},{"key":"11101_CR20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/978-981-15-8936-2_12","volume-title":"Innovations and implementations of computer aided drug discovery strategies in rational drug design","author":"R Shukla","year":"2021","unstructured":"Shukla R, Tripathi T (2021) Molecular dynamics simulation in drug discovery: opportunities and challenges. In: Singh SK (ed) Innovations and implementations of computer aided drug discovery strategies in rational drug design. Springer, Cham, pp 295\u2013316"},{"key":"11101_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1","author":"MJ Abraham","year":"2015","unstructured":"Abraham MJ, Murtola T, Schulz R et al (2015) GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1:19\u201325","journal-title":"SoftwareX"},{"key":"11101_CR22","doi-asserted-by":"publisher","first-page":"124160","DOI":"10.1016\/j.saa.2024.124160","volume":"314","author":"A Kumar","year":"2024","unstructured":"Kumar A, Singh VK, Kayastha AM (2024) Studies on \u03b1-amylase inhibition by acarbose and quercetin using fluorescence, circular dichroism, docking, and dynamics simulations. Spectrochim Acta Part A Mol Biomol Spectrosc 314:124160","journal-title":"Spectrochim Acta Part A Mol Biomol Spectrosc"},{"key":"11101_CR23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0021-9150(90)90158-F","volume":"83","author":"B Top","year":"1990","unstructured":"Top B, Koeleman BPC, Leuven JAG et al (1990) Rearrangements in the LDL receptor gene in Dutch familial hypercholesterolemic patients and the presence of a common 4 kb deletion. Atherosclerosis 83:127\u2013136","journal-title":"Atherosclerosis"},{"key":"11101_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113847","author":"EY Cotrina","year":"2021","unstructured":"Cotrina EY, Santos LM, Rivas J et al (2021) Targeting transthyretin in Alzheimer\u2019s disease: drug discovery of small-molecule chaperones as disease-modifying drug candidates for Alzheimer\u2019s disease. Eur J Med Chem. https:\/\/doi.org\/10.1016\/j.ejmech.2021.113847","journal-title":"Eur J Med Chem"},{"key":"11101_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0286195","volume":"18","author":"AA Radwan","year":"2023","unstructured":"Radwan AA, Alanazi FK, Raish M (2023) Design and synthesis of multi-functional small-molecule based inhibitors of amyloid-\u03b2 aggregation: molecular modeling and in vitro evaluation. PLoS ONE 18:1\u201320. https:\/\/doi.org\/10.1371\/journal.pone.0286195","journal-title":"PLoS ONE"},{"key":"11101_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-023-02858-y","volume":"20","author":"T Ali","year":"2023","unstructured":"Ali T, Klein AN, McDonald K et al (2023) Cellulose ether treatment inhibits amyloid beta aggregation, neuroinflammation and cognitive deficits in transgenic mouse model of Alzheimer\u2019s disease. J Neuroinflammation 20:1\u201318. https:\/\/doi.org\/10.1186\/s12974-023-02858-y","journal-title":"J Neuroinflammation"},{"key":"11101_CR27","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1021\/acschemneuro.2c00649","volume":"14","author":"S Oasa","year":"2023","unstructured":"Oasa S, Kouznetsova VL, Tiiman A et al (2023) Small molecule decoys of aggregation for elimination of A\u03b2-peptide toxicity. ACS Chem Neurosci 14:1575\u20131584. https:\/\/doi.org\/10.1021\/acschemneuro.2c00649","journal-title":"ACS Chem Neurosci"},{"key":"11101_CR28","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1021\/acschemneuro.0c00387","volume":"11","author":"S Mondal","year":"2020","unstructured":"Mondal S, Vashi Y, Ghosh P et al (2020) Amyloid targeting \u201cArtificial Chaperone\u201d impairs oligomer mediated neuronal damage and mitochondrial dysfunction associated with Alzheimer\u2019s disease. ACS Chem Neurosci 11:3277\u20133287. https:\/\/doi.org\/10.1021\/acschemneuro.0c00387","journal-title":"ACS Chem Neurosci"},{"key":"11101_CR29","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.bbrc.2019.07.074","volume":"517","author":"S Mimori","year":"2019","unstructured":"Mimori S, Kawada K, Saito R et al (2019) Indole-3-propionic acid has chemical chaperone activity and suppresses endoplasmic reticulum stress-induced neuronal cell death. Biochem Biophys Res Commun 517:623\u2013628. https:\/\/doi.org\/10.1016\/j.bbrc.2019.07.074","journal-title":"Biochem Biophys Res Commun"},{"key":"11101_CR30","doi-asserted-by":"publisher","first-page":"21937","DOI":"10.1074\/jbc.274.31.21937","volume":"274","author":"YJ Chyan","year":"1999","unstructured":"Chyan YJ, Poeggeler B, Omar RA et al (1999) Potent neuroprotective properties against the Alzheimer beta-amyloid by an endogenous melatonin-related indole structure, indole-3-propionic acid. J Biol Chem 274:21937\u201321942. https:\/\/doi.org\/10.1074\/jbc.274.31.21937","journal-title":"J Biol Chem"},{"key":"11101_CR31","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1021\/acs.jmedchem.5b01963","volume":"59","author":"P Lassalas","year":"2016","unstructured":"Lassalas P, Gay B, Lasfargeas C et al (2016) Structure property relationships of carboxylic acid isosteres. J Med Chem 59:3183\u20133203. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b01963","journal-title":"J Med Chem"},{"key":"11101_CR32","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1747-0285.2007.00483.x","volume":"69","author":"T Halgren","year":"2007","unstructured":"Halgren T (2007) New method for fast and accurate binding-site identification and analysis. Chem Biol Drug Des 69:146\u2013148. https:\/\/doi.org\/10.1111\/j.1747-0285.2007.00483.x","journal-title":"Chem Biol Drug Des"},{"key":"11101_CR33","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1021\/ci800324m","volume":"49","author":"TA Halgren","year":"2009","unstructured":"Halgren TA (2009) Identifying and characterizing binding sites and assessing druggability. J Chem Inf Model 49:377\u2013389. https:\/\/doi.org\/10.1021\/ci800324m","journal-title":"J Chem Inf Model"},{"key":"11101_CR34","volume-title":"An introduction to hydrogen bonding","author":"GA Jeffrey","year":"1997","unstructured":"Jeffrey GA (1997) An introduction to hydrogen bonding. Oxford University Press, Oxford"},{"key":"11101_CR35","doi-asserted-by":"publisher","first-page":"461","DOI":"10.2174\/1389200033489253","volume":"4","author":"K Beaumont","year":"2003","unstructured":"Beaumont K, Webster R, Gardner I, Dack K (2003) Design of ester prodrugs to enhance oral absorption of poorly permeable compounds: challenges to the discovery scientist. Curr Drug Metab 4:461\u2013485. https:\/\/doi.org\/10.2174\/1389200033489253","journal-title":"Curr Drug Metab"},{"key":"11101_CR36","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1080\/14756360701425014","volume":"22","author":"P Shah","year":"2007","unstructured":"Shah P, Westwell AD (2007) The role of fluorine in medicinal chemistry. J Enzyme Inhib Med Chem 22:527\u2013540. https:\/\/doi.org\/10.1080\/14756360701425014","journal-title":"J Enzyme Inhib Med Chem"},{"key":"11101_CR37","doi-asserted-by":"publisher","first-page":"12125","DOI":"10.1021\/ja002627n","volume":"122","author":"C-Y Kim","year":"2000","unstructured":"Kim C-Y, Chang JS, Doyon JB et al (2000) Contribution of fluorine to protein\u2212ligand affinity in the binding of fluoroaromatic inhibitors to carbonic anhydrase II. J Am Chem Soc 122:12125\u201312134. https:\/\/doi.org\/10.1021\/ja002627n","journal-title":"J Am Chem Soc"},{"key":"11101_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cmdc.202200020","volume":"202200020","author":"MR Kolk","year":"2022","unstructured":"Kolk MR, Janssen MACH, Rutjes FPJT, Blanco-Ania D (2022) Cyclobutanes in small-molecule drug candidates. ChemMedChem 202200020:1\u201322. https:\/\/doi.org\/10.1002\/cmdc.202200020","journal-title":"ChemMedChem"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-11101-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-024-11101-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-11101-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T12:28:56Z","timestamp":1763728136000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-024-11101-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,28]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["11101"],"URL":"https:\/\/doi.org\/10.1007\/s11030-024-11101-6","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"type":"print","value":"1381-1991"},{"type":"electronic","value":"1573-501X"}],"subject":[],"published":{"date-parts":[[2025,1,28]]},"assertion":[{"value":"13 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}